Monoamine Oxidase A PET/CT in Various MAO-A-Related Disease

计划入组 200 人 · 首次发布于 2026 年 7 月 6 日

A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A)

计划入组 10 人 · 首次发布于 2014 年 10 月 21 日

Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers

计划入组 76 人 · 首次发布于 2013 年 8 月 21 日

MAO-A and 5-HT2AR Dual Inhibitors I14

Safinamide(Xadago)

C₁₇H₁₉FN₂O₂ · Rx

MAO-1

A&A SMALL CHANGES HANDYPEOPLE

United States

HOSPITAL SAO RAFAEL S/A

Brazil

Novozymes A/S

Denmark

UCLA Study Reveals SSRIs May Enhance Immune Response Against Cancer

MIRA Pharmaceuticals' SKNY-1 Shows Promising Oral Bioavailability and Brain Penetration in Preclinical Obesity and Addiction Studies

Lacosamide Evaluated for Efficacy in Idiopathic Generalized Epilepsy Patients